- Published on:
Havana, nov 3 (Prensa Latina) Clinical trial Phase II with 'Abdala' and vaccine candidate 'Mambisa' for convalescents from Covid-19 in Cuba began here today, and included allergic people to thiomersal.
© 2016-2021 Prensa Latina
Latin American News Agency
Radio – Publications – Videos – News by the minute.
All Rigts Reserved.
St. E No 454 , Vedado, Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .
Web Site developed by IT Division Prensa Latina.